A J Hiller

Encapsulation of the topoisomerase I inhibitor GL147211C in pegylated (STEALTH) liposomes: pharmacokinetics and antitumor activity in HT29 colon tumor xenografts.

G T Colbern, Donald J. Dykes, C Engbers et al. · PubMed · 1998 · 50 citations

Tumor Biology, Medicinal Chemistry, Drug Targeting +15

Outgrowth of BT-474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer

H-J van Slooten, BA Bonsing, A J Hiller et al. · British Journal of Cancer · 1995 · 47 citations · Full text

Immune-deficient Mice, Breast Oncology, Cancer Immunosurveillance +10

Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicin.

Charles M Dollbaum, Abla A. Creasey, Shanaz H. Dairkee et al. · Proceedings of the National Academy of Sciences · 1988 · 34 citations

Breast Oncology, Tumor Microenvironment, Tnf Response Spectrum +15

Preliminary correlations of clinical outcome with in vitro chemosensitivity of second passage human breast cancer cells.

Helene S. Smith, W Zoli, Annalisa Volpi et al. · PubMed · 1990 · 28 citations

Breast Oncology, Pathology, Preliminary Correlations +16

Antitumor activity of Herceptin® in combination with STEALTH® liposomal cisplatin or nonliposomal cisplatin in a HER2 positive human breast cancer model

G T Colbern, A J Hiller, Randy Musterer et al. · Journal of Inorganic Biochemistry · 1999 · 26 citations

Breast Oncology, Oncology, Antitumor Activity +9